These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38562982)
21. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452 [TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of oral malignant melanomas in dogs. Blackwood L; Dobson JM J Am Vet Med Assoc; 1996 Jul; 209(1):98-102. PubMed ID: 8926220 [TBL] [Abstract][Full Text] [Related]
23. Canine oral fibrosarcomas: a retrospective analysis of 65 cases (1998-2010). Gardner H; Fidel J; Haldorson G; Dernell W; Wheeler B Vet Comp Oncol; 2015 Mar; 13(1):40-7. PubMed ID: 23418993 [TBL] [Abstract][Full Text] [Related]
24. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs. Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798 [TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691 [TBL] [Abstract][Full Text] [Related]
27. [Prognosis of canine oral (gingival) squamous cell carcinoma after surgical therapy. A retrospective analysis in 40 patients]. Kühnel S; Kessler M Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(6):359-66. PubMed ID: 25418424 [TBL] [Abstract][Full Text] [Related]
28. A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol. Baja AJ; Kelsey KL; Ruslander DM; Gieger TL; Nolan MW Vet Comp Oncol; 2022 Sep; 20(3):623-631. PubMed ID: 35338766 [TBL] [Abstract][Full Text] [Related]
29. Prognosis after surgical excision of canine melanomas. Bostock DE Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717 [TBL] [Abstract][Full Text] [Related]
30. Intralesional implant for treatment of primary oral malignant melanoma in dogs. Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382 [TBL] [Abstract][Full Text] [Related]
31. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006). Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240 [TBL] [Abstract][Full Text] [Related]
32. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). Saam DE; Liptak JM; Stalker MJ; Chun R J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373 [TBL] [Abstract][Full Text] [Related]
33. [Developmental studies on melanoma of the skin and mouth mucosa of dogs]. Frese K Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220 [TBL] [Abstract][Full Text] [Related]
34. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study]. Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072 [TBL] [Abstract][Full Text] [Related]
35. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma. Treggiari E; Grant JP; North SM J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703 [TBL] [Abstract][Full Text] [Related]
36. Curative Intent Surgery of Oral Malignant Melanoma and Regional Lymph Node Biopsy Assessment in 25 Dogs: 2006-2017. Raleigh ML; Smith MM; Taney K J Vet Dent; 2021 Dec; 38(4):193-198. PubMed ID: 35014552 [TBL] [Abstract][Full Text] [Related]
37. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells. Bernard S; Poon AC; Tam PM; Mutsaers AJ BMC Vet Res; 2021 Dec; 17(1):382. PubMed ID: 34895222 [TBL] [Abstract][Full Text] [Related]
38. Use of the melanoma vaccine in 38 dogs: The South African experience. McLean JL; Lobetti RG J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy. Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma. Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]